Study met primary endpoint of ≥15-letter (≥3-line) gain in mesopic low contrast distance visual acuity in comparison to placebo Phase 3 study showed patient-reported functional benefit in treating ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Multifocal and single vision lenses performed similarly ...
"You're not ugly, you're just not doing your makeup based on your contrast level," the most recent viral sound on TikTok tells me as soon as I open the app – bleary-eyed and half asleep at 1am. The ...
VIENNA, Austria — Compared with subcutaneous interferon β-1a (IFNB-1a; Rebif/EMD Serono/Pfizer), treatment with alemtuzumab (Lemtrada, Genzyme/Sanofi) improved visual outcomes in treatment-naive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback